摘要 |
This invention concerns compositions and methods utilizing a compound of formula (I) for reducing or controlling inflammation and treating pathological conditions mediated by intercellular adhesion. More particularly, the present invention concerns compositions and methods for blocking or modulating the function of the Beta2 Integrin family of cell adhesion molecules. |